Melio Bio is co-created with M:M Bio. A biotechnology company focussed on discovering and developing novel inhibitors of GPCRs critically implicated in cardiometabolic disease.
Company Details
- Employees
- 3
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://melio.bio/
- Keywords
- cardiometabolic disease and GPCR.
- HQ
- London
Melio Bio Questions
Melio Bio's website is https://melio.bio/
Melio Bio's LinkedIn profile is https://uk.linkedin.com/company/melio-bio
Melio Bio has
3 employees.
View email and phone details for 3
employees at Melio Bio.
Melio Bio's industry is
Biotechnology Research
Melio Bio's top competitors are
Greywolf Therapeutics,
Sygnature Discovery,
Molecule To Medicine,
Curlew Bio,
Lucia Bio,
Affivant,
Melio,
Thirtyfivebio,
Adiposs,
Pathios Therapeutics.
Melio Bio's categories are Biotechnology Research
Melio Bio's founding year is 2024
